Geneos Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Geneos Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-109	Closed	-$10K	–	3065
2021 Q4	$10K	Hold	109	–	–	﹤0.01%	2201
2021 Q3	$6K	Hold	109	–	–	﹤0.01%	2426
2021 Q2	$7K	Hold	109	–	–	﹤0.01%	2360
2021 Q1	$7K	Hold	109	–	–	﹤0.01%	2569
2020 Q4	$7K	Hold	109	–	–	﹤0.01%	2394
2020 Q3	$8K	Hold	109	–	–	﹤0.01%	2051
2020 Q2	$7K	Buy	+109	New	+$6K	﹤0.01%	2061
2018 Q2	–	Sell	-100	Closed	-$3K	–	2358
2018 Q1	$3K	Hold	100	–	–	﹤0.01%	1998
2017 Q4	$3K	Sell	100 -23,278	-100%	-$663K	﹤0.01%	1984
2017 Q3	$596K	Buy	23,378 +23,278	+23,278%	+$534K	0.06%	276
2017 Q2	$1K	Buy	+100	New	+$1.37K	﹤0.01%	2056

Geneos Wealth Management's ARNA Position: Q1 2022 in Review

Geneos Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 109 shares — an estimated $10K sold.

Geneos Wealth Management first reported a position in ARNA in Q2 2017 and held it in 11 quarters. The position peaked at $596K in Q3 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Geneos Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Geneos Wealth Management sold 109 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10K.
Geneos Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 11 quarters.
Geneos Wealth Management's Arena Pharmaceuticals Inc position peaked at $596K in Q3 2017.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.